Variable | Group | |||
---|---|---|---|---|
Total (N = 1444) | Normal CPB (N = 758) | Prolonged CPB (N = 686) | p-value | |
Age (year, N (%)) | 0.966 | |||
< 65 | 1313 (90.93) | 689 (90.90) | 624 (90.96) | |
≥65 | 131 (9.07) | 69 (9.10) | 62 (9.04) | |
Sex, N (%) | <0.001 | |||
Female | 666 (46.12) | 385 (50.79) | 281 (40.96) | |
Male | 778 (53.88) | 373 (49.21) | 405 (59.04) | |
BMI (kg/m2, N (%)) | 0.097 | |||
<23 | 649 (44.94) | 325 (42.88) | 324 (47.23) | |
≥23 | 795 (55.06) | 433 (57.12) | 362 (52.77) | |
Smoking, N (%) | 162 (11.22) | 62 (8.18) | 100 (14.58) | <0.001 |
Diabetes, N (%) | 32 (2.22) | 18 (2.37) | 14 (2.04) | 0.667 |
Hypertension, N (%) | 285 (19.74) | 169 (22.30) | 116 (16.91) | 0.010 |
Stroke, N (%) | 39 (2.7) | 32 (4.22) | 7 (1.02) | <0.001 |
Arrhythmia, N (%) | 226 (15.65) | 94 (12.40) | 132 (19.24) | <0.001 |
History of cardiovascular surgery, N (%) | 38 (2.63) | 14 (1.85) | 24 (3.50) | 0.050 |
History of VH, N (%) | 68 (4.71) | 25 (3.30) | 43 (6.27) | 0.008 |
Preop use of VA, N (%) | 169 (11.7) | 77 (10.16) | 92 (13.41) | 0.055 |
Preop use of ABX, N (%) | 133 (9.21) | 54 (7.12) | 79 (11.52) | 0.004 |
NYHA, N (%) | <0.001 | |||
I | 132 (9.14) | 82 (10.82) | 50 (7.29) | |
II | 708 (49.03) | 430 (56.73) | 278 (40.52) | |
III | 538 (37.26) | 235 (31.00) | 303 (44.17) | |
IV | 66 (4.57) | 11 (1.45) | 55 (8.02) | |
LVEF (%, M (IQR)) | 57.00 (53.00, 59.00) | 57.00 (55.00, 59.00) | 56.50 (52.00, 58.00) | <0.001 |
WBC (×109/L, M (IQR)) | 5.68 (4.78, 6.88) | 5.55 (4.73, 6.60) | 5.84 (4.83, 7.19) | <0.001 |
UA (μmol/L, M (IQR)) | 354.00 (293.00, 416.00) | 342.00 (280.00, 404.75) | 362.00 (304.00, 428.00) | <0.001 |
Creatinine (μmoI/L, M (IQR)) | 74.00 (65.00, 86.00) | 73.00 (64.00, 85.00) | 75.00 (66.00, 87.00) | 0.032 |
TC (mmol/L, M (IQR)) | 3.90 (3.27, 4.59) | 3.94 (3.31, 4.60) | 3.89 (3.23, 4.57) | 0.258 |
LDL (mmol/L, M (IQR)) | 2.50 (2.03, 3.00) | 2.52 (2.07, 3.01) | 2.49 (2.01, 2.99) | 0.250 |
GLU (mmol/L, M (IQR)) | 4.80 (4.45, 5.32) | 4.79 (4.42, 5.24) | 4.82 (4.47, 5.45) | 0.022 |
Status of the operation, N (%) | <0.001 | |||
Elective | 1391 (96.33) | 756 (99.74) | 635 (92.57) | |
Urgent | 45 (3.12) | 1 (0.13) | 44 (6.41) | |
Emergency | 8 (0.55) | 1 (0.13) | 7 (1.02) | |
Aortic surgery, N (%) | 104 (7.2) | 25 (3.30) | 79 (11.52) | <0.001 |
MAZE procedure, N (%) | 44 (3.05) | 22 (2.90) | 22 (3.21) | 0.737 |
Transfusion of blood, N (%) | 624 (43.21) | 236 (31.13) | 388 (56.56) | <0.001 |
Cross-clamp time, (min, M (IQR)) | 82 (62, 111) | 64 (54, 75) | 113 (97, 132) | <0.001 |
MHCA, N (%) | 50 (3.46) | 3 (0.40) | 47 (6.85) | <0.001 |
Type of surgery, N (%) | <0.001 | |||
Aortic valve | 722 (50) | 403 (53.17) | 319 (46.50) | |
Mitral valve | 188 (13.02) | 106 (13.98) | 82 (11.95) | |
Tricuspid valve | 32 (2.22) | 20 (2.64) | 12 (1.75) | |
Aortic+mitral valve | 145 (10.04) | 23 (3.03) | 122 (17.78) | |
Aortic+tricuspid valve | 13 (0.9) | 3 (0.40) | 10 (1.46) | |
Aortic+mitral+tricuspid valve | 250 (17.31) | 182 (24.01) | 68 (9.91) | |
Valve surgery+CABG | 94 (6.51) | 21 (2.77) | 73 (10.64) |